Molecules 2010, 15(12), 9340-9353; doi:10.3390/molecules15129340
Article

Evaluation of the Bioactivity of Novel Spiroisoxazoline TypeCompounds against Normal and Cancer Cell Lines

Nigar Najim 1,* email, Yaser Bathich 2 email, Mazatulikhma Mat Zain 1 email, Ahmad Sazali Hamzah 2 email and Zurina Shaameri 2 email
1 Tissue Culture Research Laboratory, Centre of Synthesis and Chemical Biology, Institute of Science, University Technology MARA, 40450 Shah Alam, Malaysia 2 Organic Synthesis Research Laboratory, Centre of Synthesis and Chemical Biology, Institute of Science, University Technology MARA, 40450 Shah Alam, Malaysia
* Author to whom correspondence should be addressed.
Received: 5 October 2010; in revised form: 3 November 2010 / Accepted: 2 December 2010 / Published: 17 December 2010
(This article belongs to the Special Issue Bioactive Compounds)
PDF Full-text Download PDF Full-Text [163 KB, uploaded 17 December 2010 16:23 CET]
Abstract: The aim of this study was to investigate the in vitro cellular activity of novel spiroisoxazoline type compounds against normal and cancer cell lines from lung tissue (Hs888Lu), neuron-phenotypic cells (SH-SY5Y), neuroblastoma (SH-SY5Y), human histiocytic lymphoma (U937), lung cancer (A549), and leukaemia (HL-60). Our bioassay program revealed that the spiroisoxazoline type compounds show cytotoxicity only in lymphoma cell lines, which is in contrast with the pyrrolidine precursor of these spiroisoxazoline compounds, where significant cytotoxicity is seen in all normal and cancer cell lines. These data suggest a tumour-specific mechanism of action. In addition these data also show that spiroisoxazoline compounds are non-toxic in the human neuronphenotypic neuroblastoma SH-SY5Y cell line, and furthermore that they might protect cells from neurodegenerative disease.
Keywords: pyrrolidine; spiroisoxazoline; cytotoxicity; neurotoxicity; neuroprotection

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Najim, N.; Bathich, Y.; Zain, M.M.; Hamzah, A.S.; Shaameri, Z. Evaluation of the Bioactivity of Novel Spiroisoxazoline TypeCompounds against Normal and Cancer Cell Lines. Molecules 2010, 15, 9340-9353.

AMA Style

Najim N, Bathich Y, Zain MM, Hamzah AS, Shaameri Z. Evaluation of the Bioactivity of Novel Spiroisoxazoline TypeCompounds against Normal and Cancer Cell Lines. Molecules. 2010; 15(12):9340-9353.

Chicago/Turabian Style

Najim, Nigar; Bathich, Yaser; Zain, Mazatulikhma Mat; Hamzah, Ahmad Sazali; Shaameri, Zurina. 2010. "Evaluation of the Bioactivity of Novel Spiroisoxazoline TypeCompounds against Normal and Cancer Cell Lines." Molecules 15, no. 12: 9340-9353.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert